MAXIM PHARMACEUTICALS INC
SC 13D, 1998-03-27
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: MAXIM PHARMACEUTICALS INC, 3, 1998-03-27
Next: MAXIM PHARMACEUTICALS INC, 3, 1998-03-27




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D
                                 (Rule 13d-101)

                    Under the Securities Exchange Act of 1934
                               (Amendment No. )(1)


                            Nexar Technologies, Inc.
              ----------------------------------------------------
                                (Name of Issuer)


                          Common Stock, $.001 Par Value
              ----------------------------------------------------
                         (Title of Class of Securities)


                                    57772MI07
              ----------------------------------------------------
                                 (CUSIP Number)


                             Todd J. Emmerman, Esq.
                            c/o Rosenman & Colin LLP
                               575 Madison Avenue
                               New York, NY 10022
                                  212-940-8873
              ----------------------------------------------------
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)


                                 March 31, 1997
              ----------------------------------------------------
                      (Date of Event which Requires Filing
                               of this Statement)

      If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.

     (1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

     The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
<PAGE>

CUSIP No. 57772MI07
- --------------------------------------------------------------------------------
1     Name of Reporting Person
      S.S. or I.R.S. Identification No. of Above Person

      Clearwater Fund IV, LLC
- --------------------------------------------------------------------------------
2     Check the Appropriate Box If a Member of a Group*
                                    a.  |X|
                                    b.  |_|
- --------------------------------------------------------------------------------
3     SEC Use Only

- --------------------------------------------------------------------------------
4     Source of Funds*
 
      WC
- --------------------------------------------------------------------------------
5     Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items
      2(d) or 2(e)                                                           |_|

- --------------------------------------------------------------------------------
6     Citizenship or Place of Organization

      Delaware
- --------------------------------------------------------------------------------
                  7     Sole Voting Power
  Number of
   Shares               829,000 Shares
Beneficially            --------------------------------------------------------
  Owned By        8     Shared Voting Power
    Each
  Reporting             0
   Person               --------------------------------------------------------
    With          9     Sole Dispositive Power
 
                        829,000 Shares
                        --------------------------------------------------------
                  10    Shared Dispositive Power
 
                        0
- --------------------------------------------------------------------------------
11    Aggregate Amount Beneficially Owned by Each Reporting Person

      829,000 Shares
- --------------------------------------------------------------------------------
12    Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* |_|


- --------------------------------------------------------------------------------
13    Percent of Class Represented By Amount in Row (11)

      9.0%
- --------------------------------------------------------------------------------
14    Type of Reporting Person*

      OO
- --------------------------------------------------------------------------------

                    * SEE INSTRUCTIONS BEFORE FILLING OUT!


                                     Page 2
<PAGE>

CUSIP No. 57772MI07
- --------------------------------------------------------------------------------
1     Name of Reporting Person
      S.S. or I.R.S. Identification No. of Above Person

      Clearwater Offshore Fund Ltd.
- --------------------------------------------------------------------------------
2     Check the Appropriate Box If a Member of a Group*
                                    a.  |X|
                                    b.  |_|
- --------------------------------------------------------------------------------
3     SEC Use Only

- --------------------------------------------------------------------------------
4     Source of Funds*
 
      WC
- --------------------------------------------------------------------------------
5     Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items
      2(d) or 2(e)                                                           |_|

- --------------------------------------------------------------------------------
6     Citizenship or Place of Organization

      Bahamas
- --------------------------------------------------------------------------------
                  7     Sole Voting Power
  Number of
   Shares               200,183 Shares
Beneficially            --------------------------------------------------------
  Owned By        8     Shared Voting Power
    Each
  Reporting             0
   Person               --------------------------------------------------------
    With          9     Sole Dispositive Power
 
                        200,183 Shares
                        --------------------------------------------------------
                  10    Shared Dispositive Power
 
                        0
- --------------------------------------------------------------------------------
11    Aggregate Amount Beneficially Owned by Each Reporting Person

      200,183 Shares
- --------------------------------------------------------------------------------
12    Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* |_|


- --------------------------------------------------------------------------------
13    Percent of Class Represented By Amount in Row (11)

      2.2%
- --------------------------------------------------------------------------------
14    Type of Reporting Person*

      CO
- --------------------------------------------------------------------------------

                    * SEE INSTRUCTIONS BEFORE FILLING OUT!


                                     Page 3
<PAGE>

Item 1. Security and Issuer

      This statement relates to the shares of Common Stock, .001 par value per
      share (the "Common Stock"), of Maxim Pharmaceuticals, Inc. (the
      "Company"), a corporation organized under the laws of the State of
      Delaware. The principal executive offices of the Company are located at
      3099 Science Park Road, Suite 150, San Diego, California 92121.

Item 2. Identity and Background

      (a)-(c)

      Clearwater Fund IV, LLC ("Clearwater LLC") is a Delaware limited liability
      company whose investment strategy is to make investments in debt and
      equity securities private placements. The principal business address of
      Clearwater LLC is 611 Druid Road East, Suite 200, Clearwater, Florida,
      33756. The Managing Member of Clearwater LLC is Hans Frederic Heye. Mr.
      Heye's principal business address is 611 Druid Road East, Suite 200,
      Clearwater, Florida 33756. Mr. Heye is principally employed as the
      President of the Clearwater Funds, a series of private investment
      entities.

      Clearwater Offshore Fund Ltd. ("Clearwater Offshore") is a Bahamian
      corporation whose investment strategy is to make investments in debt and
      equity securities private placements. The principal business address of
      Clearwater Offshore is c/o New World Trustees (Bahamas) Limited,
      Euro-Canadian Centre, Marlboro Street, P.O. Box N-4465, Nassau, Bahamas.
      The trading manager of Clearwater Offshore is Clearwater Futures, Inc.,
      the President of which is Mr. Heye. The address of Clearwater Futures if
      611 Druid Road East, Suite 200, Clearwater, Florida 33756. The Directors
      of Clearwater Offshore are Silkwood Nominees Ltd., a Bahamian corporation
      and Manning Consultant Ltd., a Bahamian Corporation, each of which
      principally functions as a provider of administrative services for
      offshore funds.

      Pursuant to Rule 13d-1(f)(1) promulgated under the Securities Exchange Act
      of 1934, as amended (the "Exchange Act"), this Schedule 13D is being filed
      by Clearwater Offshore and Clearwater LLC. Clearwater Offshore and
      Clearwater LLC (collectively, the "Reporting Persons") are making this
      single, joint filing because they may be deemed to constitute a "group"
      within the meaning of Section 13(d)(3) of the Exchange Act by virtue of
      the fact that Mr. Heye, the Managing Member of Clearwater LLC, is the
      President of Clearwater Futures, Inc., the trading manager of Clearwater
      Offshore.


                                     Page 4
<PAGE>

      (d) To the best knowledge of the Reporting Persons, during the last five
      years, none of the persons named in this Item 2 has been convicted in a
      criminal proceeding (excluding traffic violations or similar
      misdemeanors).

      (e) To the best knowledge of the Reporting Person, during the last five
      years, none of the persons names in this Item 2 was a party to a civil
      proceeding of a judicial or administrative body of competent jurisdiction
      which as a result of such proceeding was or is subject to any judgment,
      decree or final order enjoining future violations of, or prohibiting or
      mandating activities subject to, Federal or state securities laws or
      finding any violation with respect to such laws.

      (f) Mr. Heye is a United States citizen.

Item 3. Source and Amount of Funds or Other Consideration.

      The aggregate amount of funds used by the Reporting Persons to purchase
      the shares of Common Stock reported herein (including commissions) was
      $7,866,535. The source of funds used to purchase said shares of Common
      Stock was working capital.

Item 4. Purpose of Transaction.

      The Reporting Persons acquired the securities reported herein as being
      beneficially owned by such Reporting Persons for investment purposes.
      Depending upon market conditions and other factors that the Reporting
      Persons may deem material to their investment decisions, the Reporting
      Persons may purchase additional shares of the securities of the Company in
      the open market or in private transactions, or may dispose of all or a
      portion of the securities of the Company that it owns or hereafter may
      acquire. Except as otherwise set forth herein, the Reporting Persons have
      no plans or proposals which relate to, or could result in any matters
      referred to in paragraphs (a) through (j) of Item 4 of Schedule 13D.

Item 5. Interest in Securities of the Issuer.

      (a)-(c)

      Clearwater LLC beneficially owns 829,000 shares of the Company's Common
      Stock (comprising approximately 9.0% of the outstanding Common Stock of
      the Company as of February 6, 1998 based on the Company's Annual Report on
      Form 10-Q for the period ended December 31, 1997). Clearwater LLC has the
      sole power to vote and dispose of all such shares.


                                     Page 5
<PAGE>

      Clearwater Offshore beneficially owns 200,183 shares of the Company's
      Common Stock (comprising approximately 2.2% of the outstanding Common
      Stock of the Company as of February 6, 1998, based on the Company's Annual
      Report filed on Form 10-Q for the period ended December 31, 1997).
      Clearwater Offshore has the sole power to vote and dispose of all such
      shares.

      Collectively, Clearwater LLC and Clearwater Offshore beneficially own
      1,029,183 shares of the Company's Common Stock representing approximately
      11.2% of the outstanding shares of Common Stock of the Comapny as of as of
      February 6, 1998 based on the the Company's Annual Report on 10-Q for the
      period ended December 31, 1997.

      Each of the Reporting Persons acquired beneficial ownership of all of the
      shares of Common Stock reported herein as being beneficially owned by each
      such Reporting Person in private transactions with the Company and in open
      market purchases effected between April 30, 1997 and December 31, 1997.

      (d) Not applicable.

      (e) Not applicable.

Item 6. Contracts, Arrangements, Understandings of Relationship With Respect to
        Securities of the Issuer.

      None.

Item 7. Material to be Filed as Exhibits

      1. Agreement, dated March 17, 1998, among the Reporting Persons relating
      to the filing of a joint acquisition statement pursuant to Rule
      13d-1(f)(1).


                                     Page 6
<PAGE>

                                    SIGNATURE

      After reasonable inquiry, and to the best of our knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.

Dated:  March 17, 1998


                        CLEARWATER FUND IV, LLC                       
                                                                     
                        /s/ Hans Frederic Heye                       
                        --------------------------------------       
                        By: Hans Frederic Heye                       
                        Title: Managing Member                       
                        

                        CLEARWATER OFFSHORE FUND LTD.

                        By: MANNING CONSULTANT LTD., a director

                        By: FALKIRK S.A., as attorney-in-fact

                        /s/ Carol Goodwin
                        --------------------------------------       
                        Title: Director


                                     Page 7

<PAGE>

                                 Exhibit Index

                                                                 Sequentially
   Exhibit No.                    Description                    Numbered Page
   -----------                    -----------                    -------------

       1.          Agreement, dated March 17, 1998 among the Reporting Persons
                   relating to the Filing of a joint acquisition statement
                   pursuant to Rule 13d-1(f)(1).


                                     Page 8



                                                                     EXHIBIT 1

      The undersigned hereby agree, pursuant to Rule 13d-1(f)(1) to file a joint
statement on Schedule 13D and amendments thereto pertaining to their beneficial
ownership of shares of Common Stock of Infinite Machines Corp.

      This Agreement may be terminated for any reason by any party hereto
immediately upon the personal delivery or facsimile transmission of notice to
that effect to the other parties hereto.

      This agreement may be executed in counterparts and all so executed shall
constitute the agreement.

Date:  March 17, 1998

                        CLEARWATER FUND IV, LLC                       
                                                                     
                        /s/ Hans Frederic Heye                       
                        --------------------------------------       
                        By: Hans Frederic Heye                       
                        Title: Managing Member                       
                        

                        CLEARWATER OFFSHORE FUND LTD.

                        By: MANNING CONSULTANT LTD., a director

                        By: FALKIRK S.A., as attorney-in-fact

                        /s/ Carol Goodwin
                        --------------------------------------       
                        Title: Director


                                     Page 9



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission